APTV vs STRO
Aptiv PLC (APTV) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the APTV and STRO stock pages for the full models.
Not investment advice.